Literature DB >> 21244424

New approach for glyco- and lipidomics--molecular scanning of human brain gangliosides by TLC-Blot and MALDI-QIT-TOF MS.

Tania Valdes-Gonzalez1, Naoko Goto-Inoue, Wakako Hirano, Hironobu Ishiyama, Takahiro Hayasaka, Mitsutoshi Setou, Takao Taki.   

Abstract

We have developed a TLC-Blot system that makes possible the direct analysis of blotted glycosphingolipids on a polyvinylidene difluoride membrane from a high-performance TLC plate by immunological staining, chemical staining, enzymatic treatment and mass spectrometric (MS) analysis. An ion trap type matrix-assisted laser desorption/ionization-quadrupole ion trap-time of flight (MALDI-QIT-TOF) MS apparatus improved not only the molecular identification but also the analysis of molecular species of lipids on the polyvinylidene difluoride membrane. A new approach for glyco- and lipidomics, molecular scanning technology by a combination of TLC-Blot and MALDI-QIT-TOF MS, was developed and applied to human brain gangliosides separated from the tissues of patients with neural diseases and control patients. The results clearly showed a change of ganglioside composition, in addition to identifying individual ganglioside molecular species, in the hippocampus gray matter of patients with Alzheimer's disease. The results strongly suggested that metabolic changes of gangliosides played an important role in the progression of this disease. The present technology with molecular imaging should provide valuable information for elucidating the significance of molecular species in neuronal functions such as neural transmission, memory, and learning.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244424     DOI: 10.1111/j.1471-4159.2010.07152.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  MALDI imaging of lipid biochemistry in tissues by mass spectrometry.

Authors:  Karin A Zemski Berry; Joseph A Hankin; Robert M Barkley; Jeffrey M Spraggins; Richard M Caprioli; Robert C Murphy
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Preparation and electrophoretic separation of Bodipy-Fl-labeled glycosphingolipids.

Authors:  Scott A Sarver; Richard B Keithley; David C Essaka; Hidenori Tanaka; Yayoi Yoshimura; Monica M Palcic; Ole Hindsgaul; Norman J Dovichi
Journal:  J Chromatogr A       Date:  2012-01-18       Impact factor: 4.759

3.  Gangliosides in Neurodegenerative Diseases.

Authors:  Robert Ledeen; Suman Chowdhury
Journal:  Adv Neurobiol       Date:  2023

Review 4.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

5.  Blotting assisted by heating and solvent extraction for DESI-MS imaging.

Authors:  Elaine C Cabral; Mario F Mirabelli; Consuelo J Perez; Demian R Ifa
Journal:  J Am Soc Mass Spectrom       Date:  2013-04-20       Impact factor: 3.109

Review 6.  Gangliosides of the Vertebrate Nervous System.

Authors:  Ronald L Schnaar
Journal:  J Mol Biol       Date:  2016-05-31       Impact factor: 5.469

Review 7.  Bio-recognition and functional lipidomics by glycosphingolipid transfer technology.

Authors:  Takao Taki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

Review 8.  Ganglioside biochemistry.

Authors:  Thomas Kolter
Journal:  ISRN Biochem       Date:  2012-12-19

9.  Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry.

Authors:  Lakshini H S Mendis; Angus C Grey; Richard L M Faull; Maurice A Curtis
Journal:  Brain Behav       Date:  2016-07-14       Impact factor: 2.708

Review 10.  Recent advances in the mass spectrometric analysis of glycosphingolipidome - A review.

Authors:  Rodell C Barrientos; Qibin Zhang
Journal:  Anal Chim Acta       Date:  2020-05-24       Impact factor: 6.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.